View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in Virginia

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jul. 1, 2015-- MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Manassas Anesthesia Associates, P.C., a private physician group practice based in Manassas, Va.

Manassas Anesthesia Associates was incorporated in 1994 and employs 24 full-time clinicians (11 anesthesiologists and 13 anesthetists) that provide services at Prince William and Haymarket Medical Centers, as well as their affiliated ambulatory surgery centers. The practice’s anesthesia services include general anesthesia, orthopedic, vascular, obstetric, gynecologic and acute pain management for post-operative pain.

“The rationale for Manassas Anesthesiology Associates' decision to join MEDNAX is one of support. Although we consider our professional care of patients and coordination with the entire Health System rivaled by none, we are confident that having the support of a national medical group that is focused on research, education and quality initiatives will further enhance those services we provide to both our patients and our hospital partner,” said Ivan Harangozo, M.D., who will serve as medical director for the practice. “By aligning with MEDNAX, our practice now offers the local populace the benefits of the experience and resources of one of the nation’s largest anesthesiology networks.”

This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of neonatal, anesthesia, teleradiology, maternal-fetal and pediatric physician subspecialty services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a division of MEDNAX, was founded in 1979 and includes neonatal physicians who provide services at more than 370 neonatal intensive care units, and collaborate with affiliated maternal-fetal medicine, pediatric cardiology, pediatric critical care and other physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. American Anesthesiology, a division of MEDNAX, was established in 2007 and includes more than 2,475 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs approximately 2,700 physicians in 35 states and Puerto Rico. vRad, which MEDNAX acquired in 2015, provides teleradiology services through a network of more than 350 radiologists located in all 50 states. In addition to its national physician network, MEDNAX provides services to medical providers in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Charles Lynch, 954-384-0175, x 5692
Vice President, Strategy and Investor Relations